<p>The invention relates to an amorphous form of moxifloxacin hydrochloride and processes for preparing amorphous moxifloxacin hydrochloride. The invention also relates to pharmaceutical compositions that include the amorphous moxifloxacin hydrochloride and use of said compositions for the treatment of bacterial infections.</p>